Currently Recruiting

Lupus Clinical Trial

Clinical research for adults living with systemic lupus erythematosus (SLE).

About this study

Lupus is a chronic autoimmune condition in which the immune system attacks healthy tissue, potentially affecting joints, skin, kidneys and other organs. We participate in studies evaluating investigational therapies aimed at helping manage lupus symptoms and disease activity.

Who may qualify

  • Adults with a documented diagnosis of systemic lupus erythematosus
  • Active disease as defined by the study protocol
  • Currently on stable background therapy (study-specific)
  • Able to attend visits in Orlando, FL
Final eligibility is determined during prescreening and the in-person screening visit. Enrollment in any specific study is never guaranteed.

What to expect

  1. Prescreening call to discuss history
  2. In-person screening with labs and disease activity assessment
  3. Scheduled study visits with investigator oversight
  4. Ongoing safety monitoring throughout participation

Status

Currently Recruiting

Interested in this study? Reach out to our Orlando research team for a prescreening conversation.

Study interest form

This form is a placeholder. Please do not include sensitive medical details.

Submissions are handled securely by the Heuer M.D. Research team.

Other currently recruiting studies

Polymyositis / Dermatomyositis

Investigational studies for adults with polymyositis or dermatomyositis rare inflammatory muscle diseases.

Gout

Studies evaluating investigational treatments for adults living with chronic or recurrent gout.

Asthma

Research studies for adults living with asthma, evaluating investigational respiratory therapies.

Rheumatoid Arthritis

Investigational studies for adults living with rheumatoid arthritis (RA).

Psoriatic Arthritis

Studies for adults living with psoriatic arthritis (PsA) — joint disease associated with psoriasis.

Chronic Obstructive Pulmonary Disease (COPD)

Investigational research for adults living with chronic obstructive pulmonary disease.

Speak with the Orlando research team

Ask about currently recruiting studies, eligibility or what participation involves. Every conversation is voluntary and private.